HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,712 | +10.3% | 44,820 | +4.2% | 0.01% | 0.0% |
| Q2 2023 | $1,552 | +38.3% | 43,030 | +46.5% | 0.01% | +25.0% |
| Q1 2023 | $1,122 | -61.2% | 29,375 | -42.2% | 0.00% | -63.6% |
| Q4 2022 | $2,890 | -99.8% | 50,789 | +19.1% | 0.01% | +57.1% |
| Q3 2022 | $1,687,000 | +1.3% | 42,658 | +12.7% | 0.01% | 0.0% |
| Q2 2022 | $1,665,000 | +38.2% | 37,840 | +25.2% | 0.01% | +40.0% |
| Q1 2022 | $1,205,000 | +14.0% | 30,219 | +14.9% | 0.01% | +25.0% |
| Q4 2021 | $1,057,000 | -13.1% | 26,291 | -12.1% | 0.00% | -20.0% |
| Q3 2021 | $1,217,000 | -20.5% | 29,920 | -11.2% | 0.01% | -28.6% |
| Q2 2021 | $1,530,000 | +15.8% | 33,693 | +6.3% | 0.01% | 0.0% |
| Q1 2021 | $1,321,000 | +32.2% | 31,704 | +35.5% | 0.01% | +16.7% |
| Q4 2020 | $999,000 | -27.3% | 23,392 | -55.3% | 0.01% | -33.3% |
| Q3 2020 | $1,375,000 | -1.7% | 52,317 | +0.2% | 0.01% | 0.0% |
| Q2 2020 | $1,399,000 | – | 52,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |